What we should learn from the London Olympics

M. Bonini; C. Bachert; C.E. Baena-Cagnani; A. Bedbrook; J.L. Brozek; G.W. Canonica; A.A. Cruz; W.J. Fokkens; R. Gerth van Wijk; L. Grouse; P.W. Hellings; P. Howarth; O. Kalayci; N. Khaltaev; P. Kuna; D. Larenas Linnemann; K. Nekam; S. Palkonen; N.G. Papadopoulos; T.A. Popov; D. Price; J. Rosado Pinto; G. Rasi; D. Ryan; B. Samolinski; G.K. Scadding; H.J. Schünemann; D.M. Thomas; M. Triggiani; A. Yorgancioglu; O.M. Yusuf; T. Zuberbier; R. Pawankar; J. Bousquet; S. Bonini; ARIA Initiative, in collaboration with the WHO Collaborating Center for Asthma, Rhinitis

doi:10.1097/ACI.0b013e32835c1b73

What we should learn from the London Olympics

M. Bonini, C. Bachert, C.E. Baena-Cagnani, A. Bedbrook, J.L. Brozek, G.W. Canonica, A.A. Cruz, W.J. Fokkens, R. Gerth van Wijk, L. Grouse, P.W. Hellings, P. Howarth, O. Kalayci, N. Khaltaev, P. Kuna, D. Larenas Linnemann, K. Nekam, S. Palkonen, N.G. Papadopoulos, T.A. PopovD. Price, J. Rosado Pinto, G. Rasi, D. Ryan, B. Samolinski, G.K. Scadding, H.J. Schünemann, D.M. Thomas, M. Triggiani, A. Yorgancioglu, O.M. Yusuf, T. Zuberbier, R. Pawankar, J. Bousquet, S. Bonini, ARIA Initiative, in collaboration with the WHO Collaborating Center for Asthma, Rhinitis

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

The London Olympics have just finished. Official reports will soon become available on how many athletes participating in the games had asthma. However, as in the past [1], prevalence data will often be deducted by the number of athletes using inhaled beta-2 agonists that, according to the new 2012 World Anti-Doping Agency (WADA) rules [2▪], were on this occasion permitted for all the most commonly used short-acting and long-acting drugs, just following a declaration of use made by the athletes themselves. This self-reporting will largely influence the accuracy of estimates, which will not distinguish between clinical asthma and exercise-induced bronchoconstriction (EIB) without clinical asthma, as recently requested.

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	Current Opinion in Allergy and Clinical Immunology
Volume	13
Issue number	1
DOIs	https://doi.org/10.1097/ACI.0b013e32835c1b73
Publication status	Published - Feb 2013

Access to Document

10.1097/ACI.0b013e32835c1b73Licence: Unspecified

Cite this

Bonini, M., Bachert, C., Baena-Cagnani, C. E., Bedbrook, A., Brozek, J. L., Canonica, G. W., Cruz, A. A., Fokkens, W. J., Wijk, R. G. V., Grouse, L., Hellings, P. W., Howarth, P., Kalayci, O., Khaltaev, N., Kuna, P., Linnemann, D. L., Nekam, K., Palkonen, S., Papadopoulos, N. G., ... ARIA Initiative, in collaboration with the WHO Collaborating Center for Asthma, Rhinitis (2013). What we should learn from the London Olympics. Current Opinion in Allergy and Clinical Immunology, 13(1), 1-3. https://doi.org/10.1097/ACI.0b013e32835c1b73

Bonini, M, Bachert, C, Baena-Cagnani, CE, Bedbrook, A, Brozek, JL, Canonica, GW, Cruz, AA, Fokkens, WJ, Wijk, RGV, Grouse, L, Hellings, PW, Howarth, P, Kalayci, O, Khaltaev, N, Kuna, P, Linnemann, DL, Nekam, K, Palkonen, S, Papadopoulos, NG, Popov, TA, Price, D, Pinto, JR, Rasi, G, Ryan, D, Samolinski, B, Scadding, GK, Schünemann, HJ, Thomas, DM, Triggiani, M, Yorgancioglu, A, Yusuf, OM, Zuberbier, T, Pawankar, R, Bousquet, J, Bonini, S & ARIA Initiative, in collaboration with the WHO Collaborating Center for Asthma, Rhinitis 2013, 'What we should learn from the London Olympics', Current Opinion in Allergy and Clinical Immunology, vol. 13, no. 1, pp. 1-3. https://doi.org/10.1097/ACI.0b013e32835c1b73

@article{16f4b3b378db469ab488fe9a7ce3ffe2,

title = "What we should learn from the London Olympics",

abstract = "The London Olympics have just finished. Official reports will soon become available on how many athletes participating in the games had asthma. However, as in the past [1], prevalence data will often be deducted by the number of athletes using inhaled beta-2 agonists that, according to the new 2012 World Anti-Doping Agency (WADA) rules [2▪], were on this occasion permitted for all the most commonly used short-acting and long-acting drugs, just following a declaration of use made by the athletes themselves. This self-reporting will largely influence the accuracy of estimates, which will not distinguish between clinical asthma and exercise-induced bronchoconstriction (EIB) without clinical asthma, as recently requested.",

author = "M. Bonini and C. Bachert and C.E. Baena-Cagnani and A. Bedbrook and J.L. Brozek and G.W. Canonica and A.A. Cruz and W.J. Fokkens and Wijk, {R. Gerth van} and L. Grouse and P.W. Hellings and P. Howarth and O. Kalayci and N. Khaltaev and P. Kuna and Linnemann, {D. Larenas} and K. Nekam and S. Palkonen and N.G. Papadopoulos and T.A. Popov and D. Price and Pinto, {J. Rosado} and G. Rasi and D. Ryan and B. Samolinski and G.K. Scadding and H.J. Sch{\"u}nemann and D.M. Thomas and M. Triggiani and A. Yorgancioglu and O.M. Yusuf and T. Zuberbier and R. Pawankar and J. Bousquet and S. Bonini and {ARIA Initiative, in collaboration with the WHO Collaborating Center for Asthma, Rhinitis}",

year = "2013",

month = feb,

doi = "10.1097/ACI.0b013e32835c1b73",

language = "English",

volume = "13",

pages = "1--3",

journal = "Current Opinion in Allergy and Clinical Immunology",

issn = "1528-4050",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - What we should learn from the London Olympics

AU - Bonini, M.

AU - Bachert, C.

AU - Baena-Cagnani, C.E.

AU - Bedbrook, A.

AU - Brozek, J.L.

AU - Canonica, G.W.

AU - Cruz, A.A.

AU - Fokkens, W.J.

AU - Wijk, R. Gerth van

AU - Grouse, L.

AU - Hellings, P.W.

AU - Howarth, P.

AU - Kalayci, O.

AU - Khaltaev, N.

AU - Kuna, P.

AU - Linnemann, D. Larenas

AU - Nekam, K.

AU - Palkonen, S.

AU - Papadopoulos, N.G.

AU - Popov, T.A.

AU - Price, D.

AU - Pinto, J. Rosado

AU - Rasi, G.

AU - Ryan, D.

AU - Samolinski, B.

AU - Scadding, G.K.

AU - Schünemann, H.J.

AU - Thomas, D.M.

AU - Triggiani, M.

AU - Yorgancioglu, A.

AU - Yusuf, O.M.

AU - Zuberbier, T.

AU - Pawankar, R.

AU - Bousquet, J.

AU - Bonini, S.

AU - ARIA Initiative, in collaboration with the WHO Collaborating Center for Asthma, Rhinitis

PY - 2013/2

Y1 - 2013/2

N2 - The London Olympics have just finished. Official reports will soon become available on how many athletes participating in the games had asthma. However, as in the past [1], prevalence data will often be deducted by the number of athletes using inhaled beta-2 agonists that, according to the new 2012 World Anti-Doping Agency (WADA) rules [2▪], were on this occasion permitted for all the most commonly used short-acting and long-acting drugs, just following a declaration of use made by the athletes themselves. This self-reporting will largely influence the accuracy of estimates, which will not distinguish between clinical asthma and exercise-induced bronchoconstriction (EIB) without clinical asthma, as recently requested.

AB - The London Olympics have just finished. Official reports will soon become available on how many athletes participating in the games had asthma. However, as in the past [1], prevalence data will often be deducted by the number of athletes using inhaled beta-2 agonists that, according to the new 2012 World Anti-Doping Agency (WADA) rules [2▪], were on this occasion permitted for all the most commonly used short-acting and long-acting drugs, just following a declaration of use made by the athletes themselves. This self-reporting will largely influence the accuracy of estimates, which will not distinguish between clinical asthma and exercise-induced bronchoconstriction (EIB) without clinical asthma, as recently requested.

U2 - 10.1097/ACI.0b013e32835c1b73

DO - 10.1097/ACI.0b013e32835c1b73

M3 - Article

SN - 1528-4050

VL - 13

SP - 1

EP - 3

JO - Current Opinion in Allergy and Clinical Immunology

JF - Current Opinion in Allergy and Clinical Immunology

IS - 1

ER -

What we should learn from the London Olympics

Abstract

Access to Document

Fingerprint

Cite this